Treatment with doxorubicin plus trabectedin (Yondelis), followed by trabectedin maintenance, improved overall survival (OS) and progression-free survival (PFS) in patients with metastatic or ...
Please provide your email address to receive an email when new articles are posted on . Children and adolescents treated with doxorubicin had superior long-term heart function if they also received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results